Safety and immunogenicity of ChAdOx1 MERS vaccine candidate in healthy Middle Eastern adults (MERS002): an open-label, non-randomised, dose-escalation, phase 1b trial-Reference-Cited by-同舟云学术

Safety and immunogenicity of ChAdOx1 MERS vaccine candidate in healthy Middle Eastern adults (MERS002): an open-label, non-randomised, dose-escalation, phase 1b trial

Published:2022-01 Issue:1 Volume:3 Page:e11-e20
ISSN:2666-5247
Container-title:The Lancet Microbe
language:en
Short-container-title:The Lancet Microbe

Author:

Bosaeed Mohammad,Balkhy Hanan H,Almaziad Sultan,Aljami Haya A,Alhatmi Hind,Alanazi Hala,Alahmadi Mashael,Jawhary Ayah,Alenazi Mohammed W,Almasoud Abdulrahman,Alanazi Rawan,Bittaye Mustapha,Aboagye Jeremy,Albaalharith Nahla,Batawi Sarah,Folegatti Pedro,Ramos Lopez Fernando,Ewer Katie,Almoaikel Khalid,Aljeraisy Majed,Alothman Adel,Gilbert Sarah C,Khalaf Alharbi Naif

Publisher

Elsevier BV

Subject

Virology,Infectious Diseases,Microbiology (medical),Microbiology

Reference36 articles.

1. WHO Middle East respiratory syndrome coronavirus (MERS-CoV),2020

2. Middle East respiratory syndrome coronavirus transmission;Killerby;Emerg Infect Dis,2020

3. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia;Zaki;N Engl J Med,2012

4. Risk factors for primary Middle East respiratory syndrome coronavirus illness in humans, Saudi Arabia, 2014;Alraddadi;Emerg Infect Dis,2016

5. The emerging novel Middle East respiratory syndrome coronavirus: the “knowns” and “unknowns”;Chan;J Formos Med Assoc,2013

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Strategic vaccine stockpiles for regional epidemics of emerging viruses: A geospatial modeling framework;Vaccine;2024-10

2. MERS-CoV exposure and risk factors for MERS-CoV ELISA seropositivity among members of livestock-owning households in southern Jordan: a population based cross-sectional study;The Lancet Microbe;2024-09

3. Mucosal immunity in upper and lower respiratory tract to MERS-CoV;Frontiers in Immunology;2024-08-30

4. Vaccine Platform Comparison: Protective Efficacy against Lethal Marburg Virus Challenge in the Hamster Model;International Journal of Molecular Sciences;2024-08-05

5. A stabilized MERS-CoV spike ferritin nanoparticle vaccine elicits robust and protective neutralizing antibody responses;2024-07-01